BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38780794)

  • 1. Penile-scrotal erythrodysesthesia among rectal cancer patients receiving fluoropyrimidine-based chemoradiation: a case report series.
    Adames A; O'Brien DR; Kelly AR; Saltz LB; Garcia-Aguilar J; Zinovoy M; Williams V; Wu A; Reyngold M; Hajj C; Crane C; Cercek A; Smith JJ; Markova A; Cuaron J; McCann P; Romesser PB
    Int J Colorectal Dis; 2024 May; 39(1):75. PubMed ID: 38780794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmar-plantar erythrodysesthesia associated with scrotal and penile involvement with capecitabine.
    Sapp CM; DeSimone P
    Clin Colorectal Cancer; 2007 Jan; 6(5):382-5. PubMed ID: 17311704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palmar-plantar Erythrodysesthesia with Genital Involvement Secondary to Capecitabine Chemoradiotherapy: A Case Report.
    Hu HP; Corkum MT; Perera F
    Cureus; 2018 Dec; 10(12):e3704. PubMed ID: 30788193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scrotal and Penile Erythrodysesthesia Associated with Neoadjuvant Capecitabine Chemoradiation.
    Dricken J; Pettke E; Griffin JA; Li HY; Mehta V
    Cureus; 2020 Apr; 12(4):e7724. PubMed ID: 32432002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual scrotal and penile ulcerations together with palmar-plantar erythrodysesthesia syndrome in a patient with metastatic colon carcinoma treated with capecitabine.
    Ljubojevic Hadzavdic S; Stulhofer Buzina D; Murtezani I; Skerlev M
    J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):e304-e306. PubMed ID: 27987319
    [No Abstract]   [Full Text] [Related]  

  • 6. An exploratory study to identify risk factors for the development of capecitabine-induced Palmar Plantar Erythrodysesthesia (PPE).
    Law A; Dyson S; Anthony D
    J Adv Nurs; 2015 Aug; 71(8):1825-32. PubMed ID: 25702709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
    Eisterer W; Piringer G; DE Vries A; Öfner D; Greil R; Tschmelitsch J; Samonigg H; Sölkner L; Gnant M; Thaler J;
    Anticancer Res; 2017 May; 37(5):2683-2691. PubMed ID: 28476845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2).
    Gollins SW; Myint S; Susnerwala S; Haylock B; Wise M; Topham C; Samuel L; Swindell R; Morris J; Mason L; Levine E
    Br J Cancer; 2009 Sep; 101(6):924-34. PubMed ID: 19690550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
    Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
    J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palmar-plantar erythrodysesthesia associated with capecitabine chemotherapy: a case report.
    Kigen G; Busakhala N; Njiru E; Chite F; Loehrer P
    Pan Afr Med J; 2015; 21():228. PubMed ID: 26523170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palmar-plantar erythrodysesthesia secondary to docetaxel chemotherapy: a case report.
    Benghiat H; Al-Niaimi A
    J Med Case Rep; 2011 Feb; 5():80. PubMed ID: 21352522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot randomized double-blind, placebo-controlled study on the effects of the topical application of pyridoxine on palmar-plantar erythrodysesthesia (PPE) induced by capecitabine or pegylated liposomal doxorubicin (PLD).
    Charalambous A; Tsitsi T; Astras G; Paikousis L; Filippou E
    Eur J Oncol Nurs; 2021 Feb; 50():101866. PubMed ID: 33227569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capecitabine-Induced Genital Hand-Foot Syndrome Treated With Topical Tacrolimus.
    Chan BL; Wang T
    Cureus; 2024 Apr; 16(4):e57570. PubMed ID: 38707169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of palmar-plantar erythrodysesthesia in pretreated and unpretreated patients receiving pegylated liposomal doxorubicin.
    Miolo G; Baldo P; Bidoli E; Lombardi D; Scalone S; Sorio R; Veronesi A
    Tumori; 2009; 95(6):687-90. PubMed ID: 20210230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk-Adapted Adjuvant Chemotherapy After Concomitant Fluoropyrimidine-Radiotherapy Neoadjuvant Treatment for Patients With Resectable CT3-4 or N+ Rectal Cancer: Five-Year Disease-Free Survival Results of a Single-Center Series.
    Sastre J; Serrano JJ; Fernández C; Ramirez C; Ortega L; García-Paredes B; Corona J; Alfonso R; Córdoba S; Díaz-Rubio E
    Clin Colorectal Cancer; 2016 Jun; 15(2):128-34. PubMed ID: 26385572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma.
    Zhu J; Gu W; Lian P; Sheng W; Cai G; Shi D; Cai S; Zhang Z
    Radiat Oncol; 2013 May; 8():130. PubMed ID: 23718210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between body composition and severe diarrhea in patients treated with preoperative chemoradiation with capecitabine for rectal cancer: a single-centre cohort study.
    van Rees JM; Hartman W; Nuyttens JJME; Oomen-de Hoop E; van Vugt JLA; Rothbarth J; Verhoef C; van Meerten E
    BMC Gastroenterol; 2021 Aug; 21(1):313. PubMed ID: 34348673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving role of neoadjuvant therapy in rectal cancer.
    Schrag D
    Curr Treat Options Oncol; 2013 Sep; 14(3):350-64. PubMed ID: 23828092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe myositis of the hip flexors after pre-operative chemoradiation therapy for locally advanced rectal cancer: case report.
    Florczynski MM; Sanatani MS; Mai L; Fisher B; Moulin DE; Cao J; Louie AV; Pope JE; Leung E
    BMC Cancer; 2016 Mar; 16():243. PubMed ID: 27000107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable cT3-4 or N+ rectal cancer.
    Sastre J; Custodio A; Sanchez JC; Ortega L; Rodriguez L; Puente J; Corona J; Alfonso R; de las Heras M; Dıaz-Rubio E
    Anticancer Drugs; 2011 Feb; 22(2):185-90. PubMed ID: 21218606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.